Nonglycemic effects of dipeptidyl peptidase-4 inhibitors

The review considers the major nonglycemic effects of dipeptidyl peptidase-4 inhibitors commonly used in diabetological practice, by using as an example sitagliptin, the first and most investigated representative of this class.

Shranjeno v:
Bibliografske podrobnosti
Main Authors: A S Ametov, L L Kamynina
Format: Artigo
Jezik:Russo
Izdano: "Consilium Medicum" Publishing house 2013-01-01
Serija:Терапевтический архив
Teme:
type 2 diabetes mellitus
dipeptidyl peptidase-4 inhibitors
sitagliptin
nonglycemic effects
Online dostop:https://ter-arkhiv.ru/0040-3660/article/view/31226
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki